Cornea Research Foundation of America

03/20/2026

Current research on dry eye and IPL treatment: https://pubmed.ncbi.nlm.nih.gov/?term=%28intense+pulsed+light%29+AND+%28dry+eye%29&sort=date

03/18/2026

Dr. Price discusses the latest in neurotrophic keratitis (NK) in this video. NK is a rare and degenerative eye disease caused by impaired corneal nerves. Patients lose sensation in the cornea which can damage vision if you don't blink or produce tears enough and can lead to wounds on the surface of the eye.

WAIKOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2026, Francis W. Price Jr., MD, of Price Vision Group, discusses the latest in neurotrophic keratitis.Price said pharmaceuticals are under study for neurotrophic keratitis, nonhealing epithelial defects and limbal stem cell defici...

03/16/2026

Because of our incredible community, vision research continues to move forward. If you haven't already, be sure to review our recent impact report: https://tinyurl.com/corneareport

03/16/2026

03/16/2026

March is Women's History Month. EBAA and eye banking and cornea transplantation is lucky to be filled with impressive, trailblazing women.

One such woman is Marianne Price Ph.D., of the Cornea Research Foundation of America. The first woman (and Valedictorian) to graduate from the University of Notre Dame with an engineering degree, she is also a mother of four, member of the American Academy of Ophthalmology, on the Editorial Board of Cornea, and the recipient of EBAA's 2025 R. Townley Paton Award - the association's highest honor for physicians.

For more on Marianne and other women in eye banking, see our website:
https://restoresight.org/news/womens-history-at-ebaa/

03/11/2026

https://www.medscape.com/viewarticle/vitamin-d-deficiency-linked-dry-eye-disease-2026a10006v7?ecd=mkm_CS_260309_mscpmrk-CS_CuAr_pos1_etid8168524&uac=438161HR&impID=8168524

Adults with a deficiency of vitamin D are at increased risk for developing dry eye disease than those without low levels of the nutrient, a study finds.

03/05/2026

Peter’s Anomaly is a rare congenital eye disorder present at birth that causes central corneal clouding.

In severe cases, the cornea does not fully develop, leading to significant vision loss early in life. Some children may require a corneal transplant in infancy or early childhood to give them the best chance at vision.

Because it’s rare, families often feel isolated — but research, early diagnosis, and surgical advances are improving outcomes every year.

03/05/2026

https://www.healio.com/news/ophthalmology/20260304/photobiomodulation-revolutionary-breakthrough-or-scam

Photobiomodulation with the Valeda light delivery system was authorized in November 2024, and we have been treating patients with it since summer 2025.It seems too simple to be true that we could shine a light in someone’s eyes for a few minutes nine times every 4 months and that it would help...

02/28/2026

Today is Rare Disease Day. This week we will highlight a few rare conditions that can result in the need for a cornea transplant.

ICE (Iridocorneal Endothelial) syndrome is a rare eye condition that usually shows up in adults ages 20–50, and more often in women. Some patients may eventually need a cornea transplant.

Common symptoms can include:
• Blurry or hazy vision (from corneal swelling)
• Light sensitivity
• Changes in pupil shape
• Eye pressure that can lead to glaucoma

Learn more from the American Academy of Ophthalmology:
👉 https://www.aao.org/eye-health/diseases/iridocorneal-endothelial-syndrome-ice e

Iridocorneal endothelial syndrome (ICE) is a rare eye condition affecting corneal cells and the iris. Because ICE can lead to glaucoma, treatment is focused on managing the glaucoma.

02/27/2026

Tomorrow is Rare Disease Day.

While Fuchs endothelial corneal dystrophy remains the most common indication for cornea transplants, many are performed for rare, complex diseases that require highly specialized surgical and research expertise. Sometimes patients are born with a rare disease while others develop rare autoimmune conditions like Stevens-Johnson Syndrome that severely damage the eye.

These include conditions such as:

Peters Anomaly

Congenital Hereditary Endothelial Dystrophy (CHED)

Iridocorneal Endothelial (ICE) Syndrome

Lattice Corneal Dystrophy

Granular Corneal Dystrophy

Stevens-Johnson Syndrome

Ocular Cicatricial Pemphigoid
..and more

At the Cornea Research Foundation of America, our mission extends beyond high-volume procedures. We are committed to advancing the science of eye health and improving transplant survival through long-term outcomes analysis.

Rare diseases may affect fewer individuals — but they demand innovation, collaboration, and sustained research investment.

Today, we recognize the patients, families, clinicians, and researchers working to restore vision against the odds. If you have a rare disease causing vision loss we invite you to share your story in the comments.

02/18/2026

Physicians: CRFA Board member and Price Vision Group surgeon Matthew Feng, MD serving as moderator for Ophthalmology Virtual Journal Club on 2/25. Details here:

Does cultured allogeneic corneal transplantation therapy improve long-term outcomes over more traditional keratoplasty procedures for patients with corneal endothelial failure? Join presenter, Dr. Kathryn Colby, and moderator, Dr. Matt Feng, on Wednesday, February 25, at 5:30 PM PST for a journal club discussion of “Long-term Corneal Rejuvenation after Transplantation of Cultured Human Corneal Endothelial Cells” by Kinosh*ta et al. As always, our journal club will delve into this paper in depth and provide you with valuable insights into its implications for your practice.

How does cultured allogeneic corneal transplantation improve long-term outcomes over more traditional keratoplasty procedures for patients with corneal endothelial failure?

Register now for the Ophthalmology Virtual Journal Club on 2/25. Attend the live meeting for CME credit.

Free for Academy Members: https://ow.ly/IcA050Y7S2s

02/14/2026

Optometry education is critical to spreading current research. 2026 CE events are listed at www.cornea.org/CE